Top 30 Biotechnology VC Funds & Investors in Hungary (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Hiventures
VC Fund
|
7 | Hungary, United States, United Kingdom | Pre-Seed, Seed, Series A | Software, Information Technology, Manufacturing | $18k–$2.9M |
|
Delin Ventures
VC Fund
|
7 | United Kingdom, Germany, Hungary | Seed, Series A, Series B | Software, Biotechnology, Information Technology | $1.3M–$100M |
|
FastVentures
VC Fund
|
5 | Hungary, South Korea, United States | Seed, Series A, Series B | Software, Biotechnology, Health Care | $473k–$34M |
|
Atlantic
VC Fund
|
4 | Germany, Switzerland, United States | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $850k–$30M |
|
Accel
VC Fund
|
4 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, SaaS | $1.3M–$70M |
|
XTX Ventures
VC Fund
|
4 | United Kingdom, United States, Israel | Series A, Seed, Series B | Artificial Intelligence, Software, Machine Learning | $2M–$200M |
|
O2h Ventures
VC Fund
|
3 | United Kingdom, Hungary | Seed, Venture - Series Unknown, Series A | Biotechnology, Health Care, Pharmaceutical | $603k–$25M |
|
Bonitás Ventures
VC Fund
|
3 | Hungary | Seed, Series A, Pre-Seed | Information Technology, Software, Education | $249k–$4.5M |
|
Boston Millennia Partners
VC Fund
|
2 | United States, Israel, Hungary | Series C, Series B | Health Care, Biotechnology, Medical | $4M–$53M |
|
Portfolion
VC Fund
|
2 | Hungary, Poland, United States | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $550k–$45M |
|
Startup Campus
VC Fund
|
2 | Hungary, Switzerland, Germany | Seed, Pre-Seed | Software, Health Care, Mobile Apps | $3.5k–$977k |
|
Euroventures
VC Fund
|
2 | Hungary, United Kingdom, United States | Series A, Venture - Series Unknown, Seed | Software, Information Technology, E-Commerce | $551k–$10M |
|
Atlantic Bridge Solutions
VC Fund
|
2 | Hungary | Seed, Pre-Seed | Nutrition, Life Science, Biotechnology | |
|
The Vascular Group
VC Fund
|
2 | Hungary | Series A, Venture - Series Unknown | Biotechnology, Medical, Biopharma | |
|
Futurmed
VC Fund
|
1 | ||||
|
PMK Ventures
VC Fund
|
1 | Hungary | Venture - Series Unknown | Biopharma, Life Science, Biotechnology | |
|
Zoiros Ventures
VC Fund
|
1 | ||||
|
Mercia Fund Managers
VC Fund
|
1 | United Kingdom, United States, Hungary | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $233k–$14M |
|
Merck Global Health Innovation Fund
VC Fund
|
1 | United States, Canada, United Kingdom | Series B, Series A, Venture - Series Unknown | Health Care, Biotechnology, Information Technology | $7.5M–$72M |
|
Day One Capital
VC Fund
|
1 | Hungary, United States, Croatia | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $500k–$27M |
|
Creative Accelerator
VC Fund
|
1 | Hungary | Pre-Seed, Seed | Health Care, Medical Device, Big Data | $249k–$543k |
|
Societe Generale Asset Management
VC Fund
|
1 | France, United States, Germany | Series B, Series A | Biotechnology, Software, Health Care | $1.9M–$55M |
|
MassMutual Ventures
VC Fund
|
1 | United States, Singapore, India | Series A, Series B, Seed | Financial Services, Software, Information Technology | $2.7M–$50M |
|
Széchenyi Capital Fund Management
VC Fund
|
1 | Hungary, United Kingdom | Seed, Series A | Software, Information Technology, Internet | $624k–$1.6M |
|
Texas HALO Fund
VC Fund
|
1 | United States, Canada, Hungary | Seed, Convertible Note, Series A | Health Care, Medical Device, Software | $105k–$10M |
|
European Commission
VC Fund
|
1 | Spain, France, Germany | Grant, Seed, Pre-Seed | Software, Biotechnology, Artificial Intelligence | $55k–$51M |
|
Ambrichor
VC Fund
|
1 | Hungary | Series A | Biopharma, Biotechnology, Bioinformatics | |
|
SZTA
VC Fund
|
1 | Hungary | Venture - Series Unknown | Biopharma, Life Science, Biotechnology | |
|
Fast Ventures
VC Fund
|
1 | South Korea, Hungary, United States | Seed, Series A, Pre-Seed | Health Care, Apps, Software | $418k–$7.5M |
|
KDT Holding
VC Fund
|
1 | ||||
| Access all 39 VC funds in Hungary Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
As one of the largest and most active venture capital fund partners in Central and Eastern Europe our mission is to create new ways of equity funding for innovative small and medium-sized enterprises with high growth potential as well as more traditional businesses for the purpose of establishing a sustainable and competitive SME and enterpriseecosystem both in Hungary and in the region
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Pre-Seed, Seed, Series A
- Geography: Hungary, United States, United Kingdom
Investor stats
- Total investments: 708
- Round size: Seed $118k–$935k; Pre-Seed $18k–$138k; Series A $163k–$2.9M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $493M in 2020
Portfolio highlights
- iBar Experience Kft. — iBar provides an AI inventory app that integrates into restaurant management software. They offer products and services for pizzerias, bars, discos, hotels, and restaurants.
- SURVIOT Monitoring Kft. — SURVIOT equips bridges, tunnels and buildings with automated sensors and software, giving engineers real-time, reliable data on structural health.
- Linkio - Ecommerce Integration Portal — Integrate wholesalers into your online store easier then ever
We are partnering with remarkable entrepreneurs and scientists on the mission of our lives: elevating humanity.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Germany, Hungary
Investor stats
- Total investments: 35
- Round size: Seed $1.3M–$9.2M; Series A $5.1M–$30M; Series B $16M–$100M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $58M in 2024
Portfolio highlights
- Athernal Bio — Athernal Bio is developing targeted immunotherapies to treat blood cancer precursor conditions before cancers become established.
- Penzilla — At Penzilla, we believe it's time to make corporate pension provision the way it really should be - simple. That's why we offer a solution that helps everyone get the maximum benefit from corporate pension options. Most importantly, we enable every employer to achieve true corporate social responsibility with 100% compliance and everyemployee to receive a fair pension. This is how corporate pension provision works with Penzilla: Let's "Simply Provision" together.
- Swarm Oncology — Swarm Oncology develops personalised T cell therapies that combine in vivo priming and ex vivo optimisation to deliver safe, potent, and durable treatments, driving cancers into long-term remission.
venture capital
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Hungary, South Korea, United States
Investor stats
- Total investments: 29
- Round size: Seed $473k–$34M; Series A $1.3M–$2.3M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Cytocast — Cytocast maps the mechanistic chain from compound to clinical side effect, pathway by pathway.
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 283
- Round size: Seed $1.1M–$9.3M; Pre-Seed $850k–$3.5M; Series A $4.5M–$30M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $110M in 2022
Portfolio highlights
- Cygrid — Cygrid turns identity data into quantified risk scores and automated enforcement, delivering predictable risk reduction and measurable ROI. Our solution uses AI agents to continuously assess identity risk and reduce exposure across cloud and SaaS environments. Cygrid covers human, non-human, and AI agent identities, providing unified visibility across the entire identity landscape. We help CISOs, CTOs, CROs, and technical teams uncover hidden attack paths, reduce the identity attack surface, and make the identity space measurable, actionable, and controllable for Enterprises. Cygrid platform makes Identity risk management simple. Our team will be happy to talk to you and see how our solution will help you to manage cyber risks for identities efficient and secured. Cygrid builds a high ownership culture focused on trust, accountability, and results. We work in a flexible hybrid model, encourage direct communication, and expect initiative from every team member. We value integrity, continuous learning, and strong collaboration across product, engineering, and security. Identity Security made easy!
- 42matters — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- Lightspring — Lightspring is a photonics technology company developing advanced 3D optical interconnection solutions for photonic systems,Its platform enables precise, adaptable connections between chips, fibers, and light sources beyond traditional packaging constraints.This company focuses on scalable photonic integration to accelerate the development of high-performance optical systems.
First partner to exceptional teams everywhere
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 2569
- Round size: Seed $1.3M–$11M; Series A $4.4M–$41M; Series B $9.3M–$70M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely actively investing — fresh fund, raised $750M in 2026
Portfolio highlights
- MobStac — Developer of a cloud-based mobile marketing platform designed to connect the digital and physical worlds through the use of innovative technology. The company's platform is based on the principals of proximity marketing and engage customers in a personalized, context-aware way that leverages indoor location and proximity, enabling businessesand brands to leverage BLE beacon technology to deliver context-rich experiences to their end users.
- Krux — Use Salesforce's data management platform (DMP) to unify your data and strengthen customer relationships across every touchpoint.
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm. XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geography and industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 99
- Round size: Seed $2M–$7.6M; Series A $6M–$100M; Series B $10M–$200M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $9.6M in 2024
Portfolio highlights
- Jenesys AI — Meet Jack, your AI-powered bookkeeping agent, automates line-item extraction, GL coding, and bank reconciliation with real-time insights.
- Atomic Machines — Atomic Machines is building the Matter Compiler, an AI-native, all-digital manufacturing system that builds working micro-machines directly from code, and PrimeSwitch, its first product family.
- Flapping Airplanes — Flapping Airplanes is an artificial intelligence research lab that focuses on advancing foundational AI technologies with an emphasis on data-efficient model development and fundamental research into next-generation learning approaches. The organization’s work centers on exploring alternative training paradigms that reduce dependency on massivedatasets and compute scale, aiming to enable systems that learn with efficiency more akin to human cognition rather than brute-force training methods. Its team includes researchers and technical experts pursuing long-horizon scientific challenges in AI architecture, training mechanisms, and algorithmic innovation. Flapping Airplanes engages with investors and collaborators to support its research agenda, backing efforts that expand the theoretical and practical frontiers of artificial intelligence without immediate commercial product constraints. While the lab operates primarily as a research-first initiative, its findings are intended to inform future applications in areas such as enterprise AI, robotics, scientific discovery, and decision systems. The company’s strategy reflects a shift away from traditional scale-focused AI development toward exploring deep, principled advances in learning efficiency and model capabilities.
Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 60
- Round size: Seed $603k–$7.3M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Healx — Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AItechnology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Bonitás is more than an investor. Our team helps the brave founders to pursue their dreams and build extraordinary companies. We push because we respect. Partnering with Bonitás, founders can benefit from our unmatched network and gain experience in management support. Bonitás is proud that our backed companies also propel great causes.
Show more...Investment focus
- Industry: Information Technology, Software, Education
- Stage:Seed, Series A, Pre-Seed
- Geography: Hungary
Investor stats
- Total investments: 29
- Round size: Seed $249k–$1.7M; Series A $1.4M–$4.5M
- Lead/follow: 100% lead, 0% follow
- Last fund: May invest from a new fund soon — raised $40M in 2018
Portfolio highlights
- Cytocast — Cytocast maps the mechanistic chain from compound to clinical side effect, pathway by pathway.
- roboGaze — roboGaze provides affordable solutions to increase road safety by democratized AI driven driver monitoring system
- Gremon Systems — Gremon Systems Zrt. is a software and hardware development, manufacturing and sales company specialising in innovative solutions for agriculture, especially within the vegetable segment. The aim of the investment is to expand the company's existing portfolio of products and to support the entry into the dominant European and global markets.Gremon Systems provides innovative IT solutions to greenhouse growers that results in direct cost and yield benefits.
Boston Millennia Partners (BMP) has a long and successful history of growth capital investing on a national scope. Our Core Company Investment Strategy, combined with our international network of relationships and deep industry expertise, sets us apart from other investor groups and enables us to contribute meaningfully to our portfolio companies. The company focuses on investment opportunities within the healthcare and business services industries. Outsourcing and software as a service business companies are of particular interest for investment. Boston Millennia Partners' goal is to be supportive and effective investing partners, and establish productive relationships with its business partners that create long-term value. The company seeks to partner with entrepreneurs who share our goal of building enduring, large-scale businesses that result in personal fulfillment and superior financial returns. Over the past thirty years, it has implemented an investment approach that centers on active participation with our portfolio companies. Its goal is to be supportive and effective investing partners and establish productive relationships with its business partners that create long-term value.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series C, Series B
- Geography: United States, Israel, Hungary
Investor stats
- Total investments: 120
- Round size: Series B $4M–$53M; Series C $5.5M–$43M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $22M in 2016
Portfolio highlights
- BEKHealth — BEKhealth's AI reads EHR data to power clinical trial recruitment, feasibility, and real-world data for sponsors, CROs, and research sites.
- Korio — Tired of legacy IRT software? Korio's modern RTSM platform adapts to any protocol change, cuts mid-study time & cost, and keeps clinical trials on track.
- PHT Corporation — Clario, a part of Thermo Fisher Scientific, combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical evidence for every trial phase.
Portfolion is a USD 800M AUM VC firm investing from pre-seed to series B, from its second- and third-generation funds. Our ticket sizes range from EUR 0.5M to EUR 3M at pre-seed and seed, and EUR 5M to EUR 40M at growth stage. We aim to be the first or second investors of CEE's most ambitious founders — those determined to build companies that shape industries — with the belief that exceptional people with unreasonable commitment tend to find a way. Our multi-stage fund structure allows us to form long-term partnerships with entrepreneurs and support them consistently and flexibly at every stage of their journey.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Hungary, Poland, United States
Investor stats
- Total investments: 78
- Round size: Seed $550k–$6.6M; Series A $1.6M–$13M; Series B $4M–$45M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — raised $82M in 2020
Portfolio highlights
- Kodesage — Kodesage captures your company's collective knowledge to help understand and modernize legacy code
- Mobilfox — Mobilredfox offers phone cases and mobile accessories, focusing on protection and style for smartphones.
- GymBeam — We are a fitness e-commerce platform with sports nutrition, premium services, and fair prices. We offer a wide range of nutritional supplements and advanced foods.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Startup Campus is a decentralized global brand with four key pillars: Incubation, Consulting, Investment and Education. Startup Campus offers a solution to the most significant issue of local start-up ecosystems, the need for the recruitment of new start-ups. Beyond the continous provision of recruits, the program is capable of preparing start-upsfor investments with its support services.Startup Campus is a global program for innovative businesses from the idea phase to global market entry. With an international team and an extensive partner network, they provide training and education, incubation, international market entry and investment services in 7 major cities (London, Berlin, Singapore, Hong Kong, Shenzhen, Chengdu, Budapest) of the world.
Show more...Investment focus
- Industry: Software, Health Care, Mobile Apps
- Stage:Seed, Pre-Seed
- Geography: Hungary, Switzerland, Germany
Investor stats
- Total investments: 21
- Round size: Seed $3.5k–$196k; Pre-Seed $204k–$977k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Guru Bazar — Guru Bazar mission is to create a global Sports community in order to make Sports training more accessible for everyone. Guru Bazar empowers hundreds of freelancer Sports trainers to start and run their business, providing them new customers, administrative tools and access to training spaces. With Guru Bazar sports passionates can easily search,compare and book the sports trainers of their choice in more than 50 different sports across Switzerland.
- Super Izzy AI — Super Izzy AI offers personalized health advice for women, based on data collection and contextual understanding. Super Izzy is a chatbot, who helps track users' conditions, understand their bodies and educates about reproductive health. Taboos about women’s health result in low awareness, creating significant health risks (e.g. STIs, cancer).In person care is expensive, lacks resources and isn't scalable. Current digital solutions don't combine data collection with personalized health advice.
- RAD Intel — We believe the future of influencer marketing needs to be automated & transparent. RAD’s marketplace democratizes influencer marketing by eliminating the manpower needed to manage broken processes while giving the power of the result to our customer. We see a world where the entire influencer procurement process is simple, transparent &accessable. Influencers small, medium & large use our platform to make money without having to “create” content. Brands use RAD as a staple digital channel in the same manner they use customer acqusition channel.
Budapest-based Euroventures is one of the longest-established and leading independent private equity and venture capital firms in Central Europe, with a proven ability to achieve international exits over two decades in a fast-changing environment. It has advised or is advising five investment programmes totalling over €180m since 1989, with a focus on funding INNOVATION and GROWTH in Hungary and Central Europe. The investors in Euroventures funds have been international institutional Investors. Euroventures' nearly 50 current and former portfolio companies illustrate the commitment to provide steady support through the cycles of the regional and global economy. Its professional team members have many decades of private equity / venture capital experience between them. Recent investments have targeted growing businesses with innovative technologies in the fields of medtech, big data, security, and IoT among others. Euroventures has had an outstanding track record in supporting its portfolio companies entering global markets. As a result, it has delivered highly successful exits, including IPOs (Vienna, NASDAQ, NYSE) and several dozens of trade sales to international corporations. Euroventures is a founding member of the Hungarian Venture Capital Association and complies with the conduct, governing principles and valuation/reporting guidelines of Invest Europe.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Hungary, United Kingdom, United States
Investor stats
- Total investments: 30
- Round size: Seed $551k–$3.3M; Series A $554k–$10M; Venture - Series Unknown $3.8M–$4.3M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Datapao — Datapao is a Databricks Gold Partner delivering expert consulting, platform migrations, production-ready AI and hands-on training across the UK and Europe.
- Daytrip — Book private car transfers, round-trip day trips, or hire an hourly driver. Enjoy door-to-door rides and sightseeing in 130+ countries with local drivers.
- Hypefy — An influencer marketing platform built for brands that want to discover creators, run campaigns, and measure performance with ease.
Venture Capital, Private Equity and Management Consulting Firm
Show more...Investment focus
- Industry: Nutrition, Life Science, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Hungary
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mitomarin — We believe that mitochondria-focused research will change the world of Life Science for good. Mitochondria are the centerpiece of the metabolic approach and the sentinels of cellhealth. Mitochondrial interventions are gaining strength in fighting against disease and staying healthy in everyday life. We are among the first ones to establish a new,mitochondria-related category at the intersection of life science and the food industry. Our first compound candidate is a super-concentrated, fractionated, standardized fermented wheat germ extract from a Cold Spring Harbor Laboratory spin-off project.
The Vascular Group is a medical practice company that delivers art diagnostic and therapeutic procedures.
Show more...Investment focus
- Industry: Biotechnology, Medical, Biopharma
- Stage:Series A, Venture - Series Unknown
- Geography: Hungary
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VRG Therapeutics — VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
- Novamigra Therapeutics — Cutting-edge medical care at Agape with Framer template, where AI technology meets compassionate service. Experience personalized treatment and innovative solutions for your health needs.
Futurmed is a med asset management company.
Show more...Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cytocast — Cytocast maps the mechanistic chain from compound to clinical side effect, pathway by pathway.
PMK Ventures is a Singapore-based investment firm focused on early-stage Biotech and MedTech startups. The firm provides strategic funding, clinical R&D guidance, and global networks to help innovations reach the market.
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Hungary
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Novamigra Therapeutics — Cutting-edge medical care at Agape with Framer template, where AI technology meets compassionate service. Experience personalized treatment and innovative solutions for your health needs.
Zoiros Ventures is a venture capital firm based in Budapest.
Show more...Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cytocast — Cytocast maps the mechanistic chain from compound to clinical side effect, pathway by pathway.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 158
- Round size: Seed $233k–$2M; Series A $1.3M–$14M; Venture - Series Unknown $394k–$5.9M
- Lead/follow: 64% lead, 36% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
- Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
- MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 113
- Round size: Series A $8M–$32M; Series B $7.5M–$72M; Venture - Series Unknown $8.7M–$35M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- DropGenie — DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of discovery through the generation of standardized and compatible scientific information.
- Faro AI — The AI Platform for Clinical Development
- N-Power Medicine — N-Power Medicine specializes in drug development and clinical research.
We are an early-stage technology investor, managing privately financed funds. We seek to find and join the most exciting Central Eastern European teams on their global mission.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Hungary, United States, Croatia
Investor stats
- Total investments: 61
- Round size: Seed $521k–$6.1M; Pre-Seed $500k–$7.2M; Series A $3M–$27M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Volteum — Electric vehicle (EV) fleets made easy. Volteum helps companies transition to EVs, optimize charging, and manage electric car fleet operations efficiently.
- Veridion — Veridion is a living digital replica of the business world. Decision-grade data for enterprise scale systems
- Whalebone — Whalebone offers zero disruption cybersecurity products to Telcos, ISPs, and enterprises.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investment focus
- Industry: Health Care, Medical Device, Big Data
- Stage:Pre-Seed, Seed
- Geography: Hungary
Investor stats
- Total investments: 3
- Round size: Pre-Seed $249k–$543k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Cytocast — Cytocast maps the mechanistic chain from compound to clinical side effect, pathway by pathway.
- GenuForm AI — For Patients For Doctors For Investors
- YourAnastomosis — Why are we needed?Until recently, there were no objective methods to evaluate the quality of the practice of vessel anastomosis (vascular suture) for cardiac surgeons, vascular surgeons, and surgical trainees. It was not possible to know how one surgically created vessel suture will behave, and what its long-term effectiveness will be.How arewe solving these challenges?Our technological innovations provide objective feedback about the quality of anastomoses during surgical training. Our method can be used as a convenient and gamified system, for surgical education and training for attendees, learners from all stages of training and levels of expertise. What do we offer?Your Anastomosis offers anastomosis (vascular suture) analysis for surgeons, surgical trainees and medical students. Our technology provides simulated environments, by digitizing and blood flow conditions, and evaluating short and long-term results of the specific vessel. The innovation in our technology allows for an objective assessment of an anastomosis, creating clear surgical and technical suggestions for improvement.
SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series B, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 47
- Round size: Series A $1.9M–$55M; Series B $2.1M–$15M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — last raise in 2006
Portfolio highlights
- Netasq — Founded in 1998, Netasq is an information security company based in France. It has designed and markets Unified Threat Management solutions (hardware appliances based on a derivative of FreeBSD) which combine network and application firewall with embedded anti-virus, anti-spam, VPN and content filtering functionality with an integrated real-timeintrusion prevention technology: the ASQ (Active Security Qualification).
- Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
- METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Financial Services, Software, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, Singapore, India
Investor stats
- Total investments: 161
- Round size: Seed $2.7M–$11M; Series A $5M–$23M; Series B $7M–$50M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $150M in 2026
Portfolio highlights
- Kivo Health — Kivo Health is a telehealth lung care company that provides rehab for chronic lung disease.
- AGent Energy — AGent Energy operates a hardware and software platform that connects commercial, industrial, and institutional backup generators and other distributed energy resources to electricity markets. The company installs onsite equipment and software, monitors generator condition and utilization, and manages participation in demand-response and other gridprograms. Its platform supports remote dispatch, operational alerts, anomaly detection, compliance processes, and diagnostic data for facilities such as hospitals, manufacturers, data centers, universities, agricultural sites, retailers, and water infrastructure operators. AGent Energy shares market proceeds with participating facility owners while maintaining generator availability for backup use.
- EduFund — EduFund is India's leading education finance platform, helping parents plan, save, and pay for their child's higher education, in India or abroad. Co-founded in 2020 by Eela Dubey and Arindam Sengupta, EduFund was built on a simple conviction: most Indian families focus intensely on academic preparation for college and almost entirelyignore the financial side until it's too late. Eela Dubey, Co-founder and CEO, is a NYU graduate with a background in hedge funds on Wall Street. Arindam Sengupta, Co-founder, is a Princeton University alumnus with experience at Citadel and Reliance Capital. Together, they built EduFund to close the gap between being academically ready and financially ready for higher education. The platform offers a full suite of education finance tools, including mutual fund SIPs, fixed deposits, digital gold, and term insurance, alongside education loans, scholarship discovery, and end-to-end admissions support. Its AI-powered college cost calculator, Taara, gives parents inflation-adjusted cost estimates across 3,000+ colleges in 19+ countries in seconds, factoring in tuition, living costs, and currency risk. EduFund started out as a B2C app for consumers. EduFund's B2B platform, Vittam, serves to scale the same mission through India's MFD ecosystem, enabling wealth distributors to offer their clients a broader suite of financial products, from education loans and GIFT City funds to EB-5 global investment products and international health insurance. EduFund has served 250,000+ families and built a partner network of 40+ asset management firms and 15+ lending institutions, along with over 300 MFDs and IFA's through it's B2B vertical, Vittam. EduFund has raised $12 million in total funding, including a $6 million Series A led by Cercano Management and MassMutual Ventures. The company is also supported by angel investors.
Széchenyi Capital Fund Management, a state-owned investment company, finances micro-, small- and medium-sized companies in Hungary.
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Series A
- Geography: Hungary, United Kingdom
Investor stats
- Total investments: 8
- Round size: Seed $624k–$1.6M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Talk-A-Bot — GDPR & EU AI Act compliant enterprise chatbots. Zero hallucination, full audit trail. Custom AI chatbot solutions for banking, healthcare, government & retail.
- VRG Therapeutics — VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
- Gloster Infokommunikációs Nyrt. — Gloster Infokommunikációs Nyrt is a provider of business network solutions and multi-layered IT services. The company's product and service offerings include network infrastructure, network security, cutting-edge monitoring and collaboration solutions, and the intelligent building business. They also provide IT engineering design andinstallation, cyber protection, private cloud, and proactive monitoring services to its customers as part of its business. Companies' IT infrastructure must be highly available while also dealing with rapidly changing and increasingly frequent cyberattacks.
Early Stage Venture Investments
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, Hungary
Investor stats
- Total investments: 104
- Round size: Seed $105k–$3M; Series A $3M–$10M; Convertible Note $2.5M–$2.6M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $175k in 2021
Portfolio highlights
- Flourish Care — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds.
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Grant, Seed, Pre-Seed
- Geography: Spain, France, Germany
Investor stats
- Total investments: 310
- Round size: Seed $117k–$10M; Grant $120k–$51M; Pre-Seed $55k–$5.4M
- Lead/follow: 68% lead, 32% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Bomaq — bomaq manufactures and distributes rough-terrain and four-wheel-drive forklift trucks for material-handling applications. Its product range includes Multi Purpose models with lifting capacities from 3 to 10 tons, as well as customized machines adapted with different cabins, masts, hydraulic configurations, and other options. The equipment is used in sectors such as construction, agriculture, mining, recycling, military operations, timber, and public works. Bomaq also provides after-sales documentation, spare parts, maintenance information, technical support, dealer training, and online training. The company is developing an electric rough-terrain forklift with four-wheel drive and a 2.5-ton lifting capacity.
- Minesto — Minesto operates as a developer of marine energy technology solution in Sweden, Wales, and Northern Ireland. It develops Deep Green technology, which produces electricity from slow tidal and ocean currents through a turbine. Magnus Landberg founded Minesto in 2007. It has its headquarters in Gothenburg in Sweden.
- ADBioplastics — PLA without limits. Advanced additives and bioplastics for sustainable applications. #food #cosmetics #3Dprinting #textile #medicine #agriculture #construction
Ambrichor provides access to biological samples for the development and regulatory validation of blood-based cancer tests.
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Bioinformatics
- Stage:Series A
- Geography: Hungary
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biosystems Immunolab — Biosystems International is a biotechnology company engaged in the development of blood-based diagnostics for cancer and chronic diseases.
SZTA is a investment firm.
Show more...Investment focus
- Industry: Biopharma, Life Science, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Hungary
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Novamigra Therapeutics — Cutting-edge medical care at Agape with Framer template, where AI technology meets compassionate service. Experience personalized treatment and innovative solutions for your health needs.
Fast Ventures is a venture capital investment firm.
Show more...Investment focus
- Industry: Health Care, Apps, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: South Korea, Hungary, United States
Investor stats
- Total investments: 63
- Round size: Seed $418k–$2.6M; Series A $2M–$7.5M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Bind — Bind is a start-up that operates the mobile and PC version of 'Athler'.
- Doers — Doers is an influencer commerce platform that offers several services for connecting influencers and companies.
- Driving Teacher — You may search and compare the pricing of all driving schools countrywide in Driving Teacher, and you can help students make real-time training reservations with just a few clicks without connecting to a counselor. Furthermore, it provides an online reservation management platform to driving schools in order to automate the driving school system,as well as sales growth through customized marketing.
Asset Management
Show more...Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cytocast — Cytocast maps the mechanistic chain from compound to clinical side effect, pathway by pathway.
Biotechnology VC funding in Hungary at a glance
Stats across 46 deals from 39 investors.
Access all 39 VC funds in Hungary Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Hungary investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 39 VC funds investing in Hungary Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!